Hematology Update Hematology Department Hospital Ampang · 2018. 10. 17. · References...

48
Hematology Update Hematology Department Hospital Ampang

Transcript of Hematology Update Hematology Department Hospital Ampang · 2018. 10. 17. · References...

  • Hematology Update

    Hematology Department

    Hospital Ampang

  • Case 1History

    59 years old lady

    No known medical illness

    Presented with lower back pain for 1 month

    A/W LOA and LOW

    Pain worsening and bed bound

    Constipation

    No urinary retention

  • Physical Exam General : Pallor, Lethargic

    Vital signs :BP : 100/70 PR : 100/min Spo2 : 99% RA

    CVS /Lung /Abdomen : normal

    Spine : tenderness over the lower lumbar and right paraveretebral region

    Upper limbs : normal Lower limbs : tone normal

    power difficulty to assessreflexes normal and plantar down going

  • Investigations Hb : 8.9 TWCC: 8.1 Platelet : 110

    BUSE : urea : 18.3 Creat : 476 k : 3.0 Na : 135 Cl : 90

    Bilirubin : 10.4 Albumin : 16 Globulin : 105

    ALT : 14 ALP : 300

    Ca : 3.3,Corrected Ca : 3.78

    Mg : 1.0 PO4 : 1.2

    Lumbosacral and pelvic X-ray : multiple lytic lesion and compression fracture over L1

    U/S renal : no evidence of obstructive uropathy

  • Diagnosis ?

    Malignant Hypercalcemia

    Malignacy must be ruled out in patients that present

    with a very high calcium and no other obvious cause

  • Malignant hypercalcemia

    Occurs in about 10 to 20% of patients with cancer

    - Both solid tumors and hematological malignancy

    Most common: Breast, Lung, Multiple myeloma.

  • Signs and SymptomsInsidious symptoms and often non specific signs:

    CNS : anxiety, depression, cognitive dysfunction

    GIT : anorexia, constipation, abdominal pain,

    pancreatitis (rare)

    Renal :

    -Polyuria, polydipsia (nephrogenic DI)

    -Renal calculi less frequent than in Primary HyperPTH

    -CKD if long standing untreated hypercalcemia

    CV: Short QT interval, Supraventricular & Ventricular

    arrhythmias

  • Treatment Intavenous hydration with isotonic saline

    Volume, Volume, Volume

    Up to 5l/day

    Caution with elderly and heart problem

    Forced Diuresis / calciuresis with frusemide

    Increase renal excretion of calcium

  • Medical TherapyDrug Target

    Organ Dose Mechanism

    1)Bisphophonates Bone Palmidronate60-90mgZolendronic acid4mg

    Inhibition of Osteoclast activity and differentiation

    2) Steroid Bowel

    Tumour (lymphoma )

    Dexamethasone 4-8mg tds

    Reduced absorption of calciumInhibition of ectopic production of 1,25(OH)2D3

    3) Calcitonin Bone

    kidney

    4IU/kg SC/IM 12hourly

    Inhibition of Osteoclast activityIncrease renal excretion of calcium

  • Administration of bisphosphonates – mainstays of Rx

    Hemodialysis

    - last resort, if can’t tolerate volume expansion and /or

    rapid correction of hyperCa needed

  • Back to patient IV Drip 8 pints

    IV Palmidronate 60mg given

    Renal function back to normal

    Ca : 2.0mmol/l

    Further Ix: Multiple myeloma

  • Case 2 14 years old boy

    No known medical illness

    Presented with cough for 2 months

    SOB on exertion

    A/W LOA, LOW ( 6kg in 2 months)

    No fever

    No PTB contact, no night sweat

    No hemoptysis

    Other systemic review unremarkable

  • Physical exam Pink, Mild tachpnoea

    BP : 98/50mmHg PR : 100/min

    RR : 24 breathe/min Spo2 : 98% RA

    Facial swollen

    Dilated neck and chest wall veins

    Abdomen : hepatomegaly 2cm , no splenomegaly

    Upper limbs : not swollen

  • Investigations FBC: Hb 12.2 TWCC : 12 Platelet : 406

    Renal profile : normal

    Liver function test : normal

    LDH : 880

    Ca : 2.46

    Chest X-ray

    CT Thorax

  • Diagnosis?

    Superior Vena Cava Syndrome

  • SVC Syndrome SVC syndrome is characterized by gradual, insidious

    compression / obstruction of the superior vena cava.

    Easy to compress - SVC has a thin wall & low intravascular pressure & is surrounded by rigid structures.

    The low intravascular pressure also allows for the possibility of thrombus formation, such as catheter-induced thrombus.

    The subsequent obstruction to flow causes an increased venous pressure, which results in interstitial edema and retrograde collateral flow.

  • Causes More than 90% of patients with SVC have an associated

    malignancy as the cause. - Rapid growing high grade lymphoma - Primary mediastinal malignancies

    (thymoma and thymic cancer, extragonadal germ-cell cancer ) - Metastatic disease to the mediastinum

    Lung ca

    Infectious causes (eg, syphilis, tuberculosis) have decreased because of improvements in antibiotic therapy.

    Thrombosis from central venous instrumentation - Catheter, pacemaker, guidewire

  • Work up The diagnosis of superior vena cava syndrome (SVCS) is

    often made on clinical grounds alone

    Clinical presentation

    -Progressive shortness of breath

    -Stridor and cyanosis

    -Upper body edema,

    - Dilated chest wall vein

    - Distended neck vein

    -Distorted vision,

    -Nausea, Light-headedness

  • Imaging

    Plain radiography

    Venography

    CT chest

    MRI

  • Treatment Attention to the ABCs is essential.

    Supportive

    - Elevate the patient’s head to decrease the hydrostatic

    pressure and thereby the edema

    - High dose glucocorticoid therapy

    dexamethasone, 16-20 mg every 6-8h

    - If cerebral/airway edema is present, consider diuretics

    Endovascular shunts are increasingly used, as are thrombolytic if a thrombotic cause is present.

  • Definitive therapy

    Urgent!!!

    Obtaining a histological diagnosis before initiating treatment

    Radiotherapy

    Chemotherapy

    - Cyclophosphamide 200mg od for 3 days

    or both

  • Case 3 27 years old gentleman

    No known medical illness

    Fever for 2 weeks

    Gum bleeding for 5 days

    No other bleeding tendency

    Mild giddiness and headache

    Blurring of vision

    No vomiting

    No chest pain, no SOB

  • Physical exam Pallor, no jaundice

    Tachypnoeic , gum hypertrophy

    BP : 141/76mmHg

    PR : 110

    T: 38°C

    CVS/Lung : NAD

    Abdomen : hepatomegaly 3cm

  • Investigations Hb : 7.7 TWCC : 207 Platelet : 136

    Urea : 3.6mmol/l creat :136umol/l K: 2.6mmol/l

    LFT : Normal

    LDH : 1376u/l

    Ca: 2.09mmol/l

    FBP

  • Diagnosis?

    Hyperleukocytosis

  • Hyperleukocytosis and Leukostasis Define as TWC >100x109/L

    Leukostasis – characterised by extremely elevated blast cell count and symptoms of decreased tissue perfusion

    Presented with respiratory or neurological symptoms

    Left untreated, mortality ≈ 40%

  • Pathophysiology Increased blood viscosity in microcirculation

    Blast cell highly active and associate with release of cytokines which can exacerbate local hypoxaemia

    Leukemic blast-endothelial cell interactions lead to vascular wall disruption and bleeding,

    likely due to locally released cytokines such as TNF alpha, IL--1, and IL-4.

  • The up-regulation of adhesion receptors such as L-selectin and E-selectin which can promote adhesion to the vascular endothelium and therefore, lead to the vascular endothelium tissue invasion and poor flow through vessel

    More common in AML than ALL

    Myeloblast and monoblast are larger and less deformable , stickier

  • Signs and symptoms Respiratory distress, hypoxemia, diffuse interstitial or

    alveolar infiltrates.

    CNS

    - Confusion, somnolence, stupor, delirium, coma

    - Headache, dizziness, weakness, gait

    - Papilledema, retinal vein distention, retinal

    hemorrhages

    Coagulopathy/ DIC

    Renal Failure

  • Lab tests Cytopenia

    Increased PT/ PTT

    Hyperuricemia

    Hyperphosphatemia

    Hypocalcemia

    Hyperkalemia

    Increased Lactate-- evidence for poor tissue perfusion

  • Treatment Avoidance of transfusion of red blood cells when

    possible.

    Careful correction of coagulopathy with FFP and Platelets

    Hydration and avoid K supplement

    Prevention of Tumor Lysis

    Allopurinol/ Rasburicase

  • Cytoreduction

    Initiation of Induction Chemotherapy

    Hydroxyurea - 50 - 100mg/kg/day PO 12hrs

    Cytarabine ( Ara C ) – 100mg/m2 or 200mg od

    for 3 days

    Cyclophosphamide – 200mg/m2 or 200mg od

    for 3 days

    Steroid

    Leukopheresis – CVS, Neurological , Prapism

  • Case 4 24 yo Malay female

    Diagnosed hodgkin lymphoma in 2012

    Opt for alternative treatment

    Become quadriplegic since the past 1/52.

    Initially started with numbness then unable to move both upper limb and lower limb.

    No hx of trauma

    BO –normal

    Difficulty passing urine

  • Physical exam Vital signs stable

    Febrile

    Bulky right neck swelling and bilateral axillary nodes palpable

    NeurologicalPower bilateral UL and LL --> 0/5Sensation intactTone reduced

  • Diagnosis?

    Next Step?

  • Spinal Cord Compression

  • Imaging Urgent Imaging

    No excuse for delay

    MRI

    CT scan myelography

    X-ray- limited sensitivity and specificity

  • Spinal Cord Compression Prompt diagnosis and management to prevent

    irreversible damage and paralysis

    Causes

    - Hematology – Multiple myeloma ( plasmacytoma ),

    lymphoma

    - Solid tumours – Breast, Lung, Prostate

    - Trauma, infection and etc

    Up to 7% patients with malignancy disease

  • Signs and Symptoms Depend on the site, extent and rate of development of

    the lesion

    Back pain – 90%

    Sensory disturbance or loss – sensory level

    Reduction of power in the limbs

    Difficulty walking

    Sphincter disturbance

  • Treatment High dose steroid

    - 16-20mg 4-6hourly

    Referral – Orthopaedic team

    - Instability

    - Spinal shock

    - Diagnosis

    Radiotherapy

    Chemotherapy

  • References Hematological Emergencies

    Medicine, Volume 41, Issue 5, May 2013, Pages 306-311

    Oncologic Emergencies

    Intensive Care of the Cancer Patient

    Volume 26, Issue 1, January 2010, Pages 181–205

    Hematological Emergencies

    Annals of Oncology 18 (Supplement 1): i45–i48, 2007

    Oncologic Emergencies: Diagnosis and Treatment

    Mayo Clinic Proceedings, Volume 81, Issue 6, June 2006, Pages 835-848

    A 2011 Updated Systematic Review and Clinical Practice Guideline for the

    Management of Malignant Extradural Spinal Cord Compression

    International Journal of Radiation Oncology*Biology*Physics, Volume 84,

    Issue 2, 1 October 2012, Pages 312-317